This Metric Says You Are Smart to Sell Bottomline Technologies (EPAY)

Page 1 of 2

Bottomline Technologies (NASDAQ:EPAY) investors should pay attention to a decrease in support from the world’s most elite money managers in recent months.

To most stock holders, hedge funds are perceived as underperforming, old investment tools of years past. While there are greater than 8000 funds trading at the moment, we at Insider Monkey choose to focus on the leaders of this group, close to 450 funds. It is widely believed that this group has its hands on the majority of the hedge fund industry’s total asset base, and by watching their best equity investments, we have discovered a number of investment strategies that have historically outperformed the S&P 500 index. Our small-cap hedge fund strategy outpaced the S&P 500 index by 18 percentage points a year for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have outperformed the S&P 500 index by 23.3 percentage points in 8 months (explore the details and some picks here).

Equally as beneficial, bullish insider trading activity is a second way to parse down the investments you’re interested in. Obviously, there are a variety of reasons for an executive to downsize shares of his or her company, but just one, very obvious reason why they would initiate a purchase. Many empirical studies have demonstrated the valuable potential of this method if investors understand what to do (learn more here).

With these “truths” under our belt, we’re going to take a peek at the latest action regarding Bottomline Technologies (NASDAQ:EPAY).

What does the smart money think about Bottomline Technologies (NASDAQ:EPAY)?

At Q1′s end, a total of 7 of the hedge funds we track were long in this stock, a change of -22% from the first quarter. With hedge funds’ capital changing hands, there exists a select group of key hedge fund managers who were increasing their holdings meaningfully.

Bottomline Technologies (NASDAQ:EPAY)According to our comprehensive database, John Murphy’s Alydar Capital had the largest position in Bottomline Technologies (NASDAQ:EPAY), worth close to $7.1 million, comprising 0.5% of its total 13F portfolio. Sitting at the No. 2 spot is Royce & Associates, managed by Chuck Royce, which held a $2 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Remaining hedge funds that are bullish include D. E. Shaw’s D E Shaw, Paul Tudor Jones’s Tudor Investment Corp and Israel Englander’s Millennium Management.

Due to the fact that Bottomline Technologies (NASDAQ:EPAY) has experienced bearish sentiment from the entirety of the hedge funds we track, logic holds that there were a few fund managers that slashed their positions entirely at the end of the first quarter. Interestingly, Glenn Russell Dubin’s Highbridge Capital Management said goodbye to the largest stake of the “upper crust” of funds we track, worth about $8.2 million in stock., and Richard Driehaus of Driehaus Capital was right behind this move, as the fund dumped about $1.3 million worth. These moves are important to note, as total hedge fund interest fell by 2 funds at the end of the first quarter.

How are insiders trading Bottomline Technologies (NASDAQ:EPAY)?

Bullish insider trading is particularly usable when the primary stock in question has experienced transactions within the past 180 days. Over the latest six-month time frame, Bottomline Technologies (NASDAQ:EPAY) has seen zero unique insiders buying, and 7 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Bottomline Technologies (NASDAQ:EPAY). These stocks are Blackbaud, Inc. (NASDAQ:BLKB), Interactive Intelligence Group Inc (NASDAQ:ININ), MicroStrategy Incorporated (NASDAQ:MSTR), NetScout Systems, Inc. (NASDAQ:NTCT), and Pegasystems Inc. (NASDAQ:PEGA). All of these stocks are in the business software & services industry and their market caps are closest to EPAY’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!